GENIL overview

GEN İLAÇ VE (GENIL) — Income Statement

Detailed income statement with YoY comparison · latest 6A26

Income statement and cash flow are cumulative (6A = 6-month cumulative, 12A = full year). YoY Δ compares the same period last year.

Line item6A263A2612A259A256A253A25YoY Δ
Hasılat14.06B6.62B19.18B14.36B8.38B3.86B+67.7%
Satışların Maliyeti-10.48B-4.67B-15.16B-11.42B-6.61B-3.03B+58.6%
TİCARİ FAALİYETLERDEN BRÜT KAR (ZARAR)3.57B1.95B4.02B2.94B1.77B828.1M+101.7%
BRÜT KAR (ZARAR)3.57B1.95B4.02B2.94B1.77B828.1M+101.7%
Genel Yönetim Giderleri-440.7M-256.8M-731.2M-523.4M-349.0M-196.4M+26.3%
Pazarlama Giderleri-1.07B-522.9M-1.89B-1.22B-803.1M-387.9M+33%
Araştırma ve Geliştirme Giderleri-75.0M-22.3M-47.1M-26.1M-23.7M+215.8%
Esas Faaliyetlerden Diğer Gelirler266.3M154.1M1.64B1.25B975.7M614.7M-72.7%
Esas Faaliyetlerden Diğer Giderler-206.0M-101.4M-1.10B-900.4M-657.8M-326.9M-68.7%
ESAS FAALİYET KARI (ZARARI)2.05B1.20B1.89B1.51B913.8M531.6M+124.3%
Yatırım Faaliyetlerinden Gelirler42.1M4.3M241.7M33.0M22.8M9.4M+84.6%
Yatırım Faaliyetlerinden Giderler-210.9M-198.6M-12.4M-11.1M-10.3M-7.9M+1957.2%
FİNANSMAN GELİRİ (GİDERİ) ÖNCESİ FAALİYET KARI (ZARARI)1.88B1.01B2.12B1.54B926.3M533.0M+103.1%
Finansman Gelirleri70.7M34.1M625.0M159.0M108.8M33.3M-35%
Finansman Giderleri-878.6M-256.7M-1.14B-793.6M-512.8M-185.1M+71.4%
Net Parasal Pozisyon Kazançları (Kayıpları)-210.3M-265.9M-124.5M39.7M35.5M75.0M
SÜRDÜRÜLEN FAALİYETLER VERGİ ÖNCESİ KARI (ZARARI)863.0M518.7M1.49B940.9M557.9M456.3M+54.7%
Sürdürülen Faaliyetler Vergi (Gideri) Geliri26.4M-144.3M-680.2M-283.3M-144.8M-140.0M
Dönem Vergi (Gideri) Geliri-183.8M-65.0M-149.3M-22.0M-38.0M-27.8M+383.6%
Ertelenmiş Vergi (Gideri) Geliri210.2M-79.3M-531.0M-261.3M-106.8M-112.2M
SÜRDÜRÜLEN FAALİYETLER DÖNEM KARI (ZARARI)889.4M374.4M805.7M657.6M413.1M316.3M+115.3%
DÖNEM KARI (ZARARI)889.4M374.4M805.7M657.6M413.1M316.3M+115.3%
Kontrol Gücü Olmayan Paylar-2.4M-702K-8.8M-6.3M-3.7M-3.5M-36.4%
Ana Ortaklık Payları891.8M375.1M814.4M663.9M416.8M319.8M+113.9%
Pay Başına Kazanç138.0M

GEN İLAÇ VE (GENIL) Income Statement

GEN İLAÇ VE (GENIL) Income Statement

This page shows the income statement of GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. (GENIL) as reported to the Turkish Public Disclosure Platform (KAP), broken down line by line across the most recent periods, with year-over-year percentage change so you can compare each figure to the same period last year.

Latest period 6A26: TİCARİ FAALİYETLERDEN BRÜT KAR (ZARAR): 3.57B TL (YoY +101.7%) · BRÜT KAR (ZARAR): 3.57B TL (YoY +101.7%) · ESAS FAALİYET KARI (ZARARI): 2.05B TL (YoY +124.3%).

How to read this statement

The income statement and cash flow statement are cumulative: the 6-month column covers the first two quarters combined, the 9-month column the first three, and the full-year column all four. Compare each period to the same period last year (YoY) for a like-for-like view.

Frequently Asked Questions

Where does GENIL's income statement data come from?

The figures are sourced from GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş.'s official quarterly financial statements filed with KAP (the Turkish Public Disclosure Platform) and updated automatically after each new disclosure.

Is the income statement cumulative or per quarter?

The income statement and cash flow statement are cumulative within the year (6-month, 9-month, full-year), matching the official filings.

Is GENIL financial data free on Borsafolio?

Yes. Balance sheet, income statement and cash flow statements for every BIST company are free and require no signup.